•
Sep 30, 2021

DaVita Q3 2021 Earnings Report

DaVita's financial and operating results were announced for the quarter ended September 30, 2021.

Key Takeaways

DaVita Inc. reported a strong third quarter with consolidated revenues of $2.938 billion and diluted earnings per share of $2.36. The company continues to provide high-quality care amidst a challenging operating environment, including rising COVID-19 cases and a difficult labor market.

Consolidated revenues reached $2.938 billion.

Operating income amounted to $475 million.

Diluted earnings per share were reported at $2.36.

Operating and free cash flow from continuing operations were $567 million and $358 million, respectively.

Total Revenue
$2.94B
Previous year: $2.92B
+0.5%
EPS
$2.36
Previous year: $1.8
+31.1%
US Dialysis Treatments
7.47M
Previous year: 7.66M
-2.5%
US Avg Treatments per day
94.51K
Previous year: 96.91K
-2.5%
US Revenue per Treatment
$361
Previous year: $350
+3.1%
Gross Profit
$930M
Previous year: $952M
-2.4%
Cash and Equivalents
$1.05B
Previous year: $711M
+47.2%
Free Cash Flow
$358M
Previous year: $287M
+24.7%
Total Assets
$17.6B
Previous year: $17B
+3.4%

DaVita

DaVita

DaVita Revenue by Segment

DaVita Revenue by Geographic Location

Forward Guidance

DaVita provided adjusted operating income guidance between $1.76 billion and $1.81 billion, adjusted diluted net income per share between $8.80 and $9.15, and free cash flow from continuing operations between $1.0 billion and $1.2 billion for 2021.